3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
0.4597 -2.2227 0.0401 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7403 -2.4415 -0.3101 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6759 -2.0193 0.3945 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.8791 -0.2964 -0.3165 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1034 1.8925 -0.3075 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1867 0.2994 -0.5746 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9362 0.6333 0.7097 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2458 0.5466 -0.1892 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4716 -0.0388 0.0552 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7767 -1.6804 -0.2028 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3100 1.2349 0.4497 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5912 -1.4926 0.1776 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6002 0.7750 0.1851 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4713 2.1519 0.0667 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2099 2.6580 -0.1780 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7846 -0.4110 -1.1593 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.0773 1.1872 -1.2086 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.0531 -0.2722 1.3174 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.3486 1.3365 1.3119 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.9404 0.5400 -0.1139 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.8115 1.4594 1.3963 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.2268 2.1651 -0.1212 H 0 0 0 0 0 0 0 0 0 0 0 0
3.5827 0.3531 0.3777 H 0 0 0 0 0 0 0 0 0 0 0 0
3.3302 2.8055 0.1631 H 0 0 0 0 0 0 0 0 0 0 0 0
1.0474 3.7257 -0.2800 H 0 0 0 0 0 0 0 0 0 0 0 0
1 10 1 0 0 0 0
1 12 1 0 0 0 0
2 10 2 0 0 0 0
3 12 2 0 0 0 0
4 6 1 0 0 0 0
4 8 1 0 0 0 0
4 10 1 0 0 0 0
5 8 1 0 0 0 0
5 15 2 0 0 0 0
6 7 1 0 0 0 0
6 16 1 0 0 0 0
6 17 1 0 0 0 0
7 11 1 0 0 0 0
7 18 1 0 0 0 0
7 19 1 0 0 0 0
8 9 2 0 0 0 0
9 12 1 0 0 0 0
9 13 1 0 0 0 0
11 20 1 0 0 0 0
11 21 1 0 0 0 0
11 22 1 0 0 0 0
13 14 2 0 0 0 0
13 23 1 0 0 0 0
14 15 1 0 0 0 0
14 24 1 0 0 0 0
15 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
1-propylpyrido[2,3-d][1,3]oxazine-2,4-dione
4.2 InChl
InChI=1S/C10H10N2O3/c1-2-6-12-8-7(4-3-5-11-8)9(13)15-10(12)14/h3-5H,2,6H2,1H3
4.3 InChlKey
NEVBYCDQGXFCCZ-UHFFFAOYSA-N
4.4 Canonical SMILES
CCCN1C2=C(C=CC=N2)C(=O)OC1=O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病